Mycobacterium chelonae in a CF patient with anaplastic large cell lymphoma

作者: E. Tschiedel , H. Grasemann , F. Ratjen

DOI: 10.1016/J.JCF.2005.11.004

关键词: MedicineImmunosuppressionMycobacterium chelonaePathologyChemotherapyNontuberculous mycobacteriaSputumCystic fibrosisAnaplastic large-cell lymphomaLymphoma

摘要: A 13-year-old patient with cystic fibrosis was diagnosed anaplastic large cell lymphoma. At the same time colonization Mycobacterium chelonae detected in sputum cultures. Despite massive immunosuppression, did not show evidence of mycobacterial invasive disease. Colonisation persisted for 18 months after discontinuation chemotherapy and 6 years thereafter. This case highlights dilemma differentiating between colonisation infection if mycobacteria are found CF samples.

参考文章(22)
Luis Máiz Carro, Enrique Navas Elorza, Nontuberculous Mycobacterial Pulmonary Infection in Patients with Cystic Fibrosis American journal of respiratory medicine : drugs, devices, and other interventions. ,vol. 1, pp. 107- 117 ,(2002) , 10.1007/BF03256600
ANNE R. CULLEN, CAROLYN L. CANNON, EUGENE J. MARK, ANDREW A. COLIN, Mycobacterium abscessus infection in cystic fibrosis. Colonization or infection American Journal of Respiratory and Critical Care Medicine. ,vol. 161, pp. 641- 645 ,(2000) , 10.1164/AJRCCM.161.2.9903062
W. Fabry, E. N. Schmid, R. Ansorg, Comparison of the E test and a proportion dilution method for susceptibility testing of Mycobacterium avium complex Journal of Medical Microbiology. ,vol. 44, pp. 227- 230 ,(1996) , 10.1099/00222615-44-3-227
Rose Ann Padua, Neil Warren, David Grimshaw, Melissa Smith, Christopher Lewis, Jack Whittaker, Peter Laidler, Patricia Wright, Anthony Douglas-Jones, Pierre Fenaux, Anup Sharma, Kieran Horgan, Robert West, The cystic fibrosis ΔF508 gene mutation and cancer Human Mutation. ,vol. 10, pp. 45- 48 ,(1997) , 10.1002/(SICI)1098-1004(1997)10:1<45::AID-HUMU6>3.0.CO;2-L
U Forslöw, A Geborek, L Hjelte, B Petrini, N Heurlin, Early chemotherapy for non-tuberculous mycobacterial infections in patients with cystic fibrosis. Acta Paediatrica. ,vol. 92, pp. 910- 915 ,(2007) , 10.1111/J.1651-2227.2003.TB00623.X
J F Tomashefski, R C Stern, C A Demko, C F Doershuk, Nontuberculous mycobacteria in cystic fibrosis. An autopsy study. American Journal of Respiratory and Critical Care Medicine. ,vol. 154, pp. 523- 528 ,(1996) , 10.1164/AJRCCM.154.2.8756832
Pernille Ravn, Martin E. Munk, Åse Bengaard Andersen, Bettina Lundgren, Lars N. Nielsen, Troels Lillebaek, Inge J. Soerensen, Peter Andersen, Karin Weldingh, Reactivation of Tuberculosis During Immunosuppressive Treatment in a Patient with a Positive QuantiFERON®-RD1 Test Scandinavian Journal of Infectious Diseases. ,vol. 36, pp. 499- 501 ,(2004) , 10.1080/00365540410015222
Kenneth N. Olivier, David J. Weber, Ji-Hyun Lee, Allison Handler, Gail Tudor, Paul L. Molina, Joseph Tomashefski, Michael R. Knowles, Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease. American Journal of Respiratory and Critical Care Medicine. ,vol. 167, pp. 835- 840 ,(2003) , 10.1164/RCCM.200207-679OC
G Steinkamp, B Wiedemann, E Rietschel, A Krahl, J Gielen, H Bärmeier, F Ratjen, Emerging Bacteria Study Group, Prospective evaluation of emerging bacteria in cystic fibrosis. Journal of Cystic Fibrosis. ,vol. 4, pp. 41- 48 ,(2005) , 10.1016/J.JCF.2004.10.002
BRIGITTE FAUROUX, BERTRAND DELAISI, ANNICK CLÉMENT, CAROLE SAIZOU, DIDIER MOISSENET, CHANTAL TRUFFOT-PERNOT, GUY TOURNIER, HOANG VU THIEN, Mycobacterial lung disease in cystic fibrosis: a prospective study Pediatric Infectious Disease Journal. ,vol. 16, pp. 354- 358 ,(1997) , 10.1097/00006454-199704000-00004